Table 1.
Without antibiotics (n=29) | With antibiotics (n=19) | p-value | |
---|---|---|---|
Age, median (IQR) | 66 [60; 71] | 67 [60; 72] | 0.74 |
Sex, female | 5 (17.2) | 6 (31.6) | 0.25 |
≥1 comorbidity | 22 (75.9) | 16 (84.2) | 0.49 |
Cardiovascular disease | 11 (37.9) | 3 (15.8) | 0.12 |
Diabetes mellitus | 7 (24.1) | 6 (31.6) | 0.57 |
Hypertension | 16 (55.2) | 8 (42.1) | 0.38 |
Lymphopenia at admission, median (IQR) | 0.7 [0.6; 0.9] | 0.7 [0.4; 0.9] | 0.33 |
CRP at admission, median (IQR) | 128 [57; 206] | 83 [47; 132] | 0.29 |
Creatinin at admission, median (IQR) | 95 [84; 118] | 98 [81; 128] | 0.92 |
Lymphopenia duration, median (IQR) | 23 [16; 31] | 25 [23; 35] | 0.11 |
SAPS at ICU admission, median (IQR) | 45 [40; 65] | 47 [37; 55] | 0.79 |
Corticosteroids during ICU stay | 15 (51.7) | 10 (52.6) | 0.95 |
Antivirals* | 14 (48.3) | 13 (68.4) | 0.17 |
Tocilizumab | 3 (10.3) | 2 (10.5) | 0.99 |
Healthcare-associated infections during ICU stay | |||
Infection number per patient, median (IQR) | 1 [1; 2] | 1 [1; 2] | 0.98 |
VAP | 19 (65.5) | 14 (73.7) | 0.55 |
UTI | 8 (27.6) | 2 (10.5) | 0.28 |
CRBSI | 7 (24.1) | 5 (26.3) | 0.86 |
Colitis | 0 (0) | 1 (5.3) | 0.39 |
Candidemia | 2 (6.9) | 3 (15.8) | 0.37 |
Mortality | 7 (24.1) | 5 (26.3) | 0.86 |
Legends. *Antivirals commonly administered at our institution were: hydroxychloroquin, lopinavir/ritonavir and remdesivir. IQR: interquartile range. CRP: C-reactive protein. SAPS: Simplified Acute Physiology Score. ICU: Intensive care unit. VAP: Ventilator-associated pneumonia. UTI: Urinary tract infection. CRBSI: Catheter-related bloodstream infection.